Login / Signup

To Transplant or Not? Weighing the Risks of Blinatumomab Prior to Hematopoietic Stem Cell Transplant in Acute Lymphoblastic Leukemia.

Punita GroverEmily Curran
Published in: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation (2020)
Keyphrases
  • acute lymphoblastic leukemia
  • hematopoietic stem cell
  • allogeneic hematopoietic stem cell transplantation
  • human health
  • risk assessment